Enanta Pharmaceuticals Inc. (ENTA)
NASDAQ · Healthcare
Enanta Pharmaceuticals Inc. Shareholder Equity 2020–2025
Enanta Pharmaceuticals Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Enanta Pharmaceuticals Inc. shareholder equity as of September 30, 2025: 64.7M, a 49.76% decrease year-over-year.
- Enanta Pharmaceuticals Inc. shareholder equity for 2025 were 64.7M, a 49.76% decrease from 2024.
- Enanta Pharmaceuticals Inc. shareholder equity for 2024 were 128.8M, a 40.57% decrease from 2023.
- Enanta Pharmaceuticals Inc. shareholder equity for 2023 were 216.7M, a 32.55% decrease from 2022.
- Enanta Pharmaceuticals Inc. shareholder equity for 2022 were 321.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Enanta Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $65 |
| 2024 | $129 |
| 2023 | $217 |
| 2022 | $321 |
| 2021 | $399 |
| 2020 | $456 |
Enanta Pharmaceuticals Inc. Shareholder Equity — FAQ
Enanta Pharmaceuticals Inc. (ENTA) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ENTA's shareholder equity history?
The chart and table above show Enanta Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.